IMAX (IMAX) CEO Richard Gelfond Details RSU Vesting and Updated Holdings

Rhea-AI Filing Summary

IMAX Corporation chief executive officer and director Richard L. Gelfond reported multiple equity transactions on January 2, 2026 involving IMAX common shares and restricted share units. Vested restricted share units were converted into common shares at an exercise price of $0.00, and a portion of those shares was withheld at a price of $36.02 per share to cover related tax obligations. Following these transactions, Mr. Gelfond beneficially owns 635,940 IMAX common shares directly, along with outstanding equity awards consisting of 1,818,695 options and 231,562 restricted share units. The restricted share units are scheduled to vest in installments through January 2, 2029, each unit representing the right to receive one IMAX common share.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GELFOND RICHARD L

(Last) (First) (Middle)

902 BROADWAY

20TH FLOOR

(Street)

NEW YORK 10010-6002

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IMAX CORP [ IMAX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
common shares (opening balance)								564,599	D
common shares	01/02/2026		M		62,529(1)	A	$0.00	627,128	D
common shares	01/02/2026		F		34,859(2)	D	$36.02	592,269	D
common shares	01/02/2026		M		61,193(1)	A	$0.00	653,462	D
common shares	01/02/2026		F		33,840(2)	D	$36.02	619,622	D
common shares	01/02/2026		M		36,506(1)	A	$0.00	656,128	D
common shares	01/02/2026		F		20,188(2)	D	$36.02	635,940	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
restricted share units(3)	$0.00(4)	01/02/2026		M			62,529(1)	(5)	(5)	common shares	62,529	$0.00(4)	0(9)	D
restricted share units(3)	$0.00(4)	01/02/2026		M			61,193(1)	(6)	(6)	common shares	61,193	$0.00(4)	61,193(9)	D
restricted share units(3)	$0.00(4)	01/02/2026		M			36,506	(7)	(7)	common shares	36,506	$0.00(4)	73,012(9)	D
restricted share units(3)	$0.00(4)	01/02/2026		A			97,357	(8)	(8)	common shares	97,357	$0.00(4)	97,357(9)	D

Explanation of Responses:

1. Represents the conversion of vested restricted share units into common shares.

2. Mr. Gelfond is reporting the withholding of common shares by IMAX Corporation to satisfy the tax withholding obligation in connection with the delivery of common shares upon conversion of the restricted share unit transaction.

3. Each restricted share unit represents a contingent right to receive one common share of IMAX Corporation.

4. Each restricted share unit is the economic equivalent of one common share of IMAX Corporation.

5. The restricted share units vest and will be converted to common shares in three installments: 62,528 on each of January 2, 2024 and January 2, 2025 and 62,529 on January 2, 2026.

6. The restricted share units vest and will be converted to common shares in three installments: 61,192 on January 2, 2025 and 61,193 on each of January 2, 2026 and January 2, 2027.

7. The restricted share units vest and will be converted to common shares in three installments: 36,506 on each of January 2, 2026, January 2, 2027 and January 2, 2028.

8. The restricted share units vest and will be converted to common shares in three installments: 32,452 on each of January 2, 2027, January 2, 2028 and 32,453 January 2, 2029.

9. This represents the number of restricted share units for this transaction only. Mr. Gelfond's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 1,818,695; 231,562 and 635,940 respectively.

Remarks:

	/s/ Richard L. Gelfond	01/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did IMAX (IMAX) CEO Richard Gelfond report in this Form 4?

Richard L. Gelfond reported the conversion of vested restricted share units into IMAX common shares on January 2, 2026, along with share withholding transactions to cover tax obligations.

How many IMAX common shares does Richard Gelfond own after these transactions?

After the reported transactions, Richard Gelfond beneficially owns 635,940 IMAX common shares directly.

What equity awards in IMAX does Richard Gelfond still hold after this filing?

Following these transactions, Richard Gelfond holds 1,818,695 stock options, 231,562 restricted share units, and 635,940 IMAX common shares.

How were taxes handled on Richard Gelfond’s IMAX share deliveries?

IMAX Corporation withheld common shares from the deliveries at a price of $36.02 per share to satisfy Richard Gelfond’s tax withholding obligations related to the restricted share unit conversions.

What does each IMAX restricted share unit reported by Richard Gelfond represent?

Each restricted share unit reported represents a contingent right to receive one IMAX common share and is described as the economic equivalent of one common share.

Over what period will Richard Gelfond’s IMAX restricted share units vest?

The restricted share units described are scheduled to vest and convert into IMAX common shares in installments on January 2 of various years, with vesting extending through January 2, 2029.